SCHEMBL900057

SCHEMBL900057

Cc1ccncc1-c1ccc(-n2cnc3ccccc32)cc1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 3/20 0.57
HTT P42858 5/20 0.56
MAPT P10636 4/20 0.54
KMT2A Q03164 3/20 0.54
NPSR1 Q6W5P4 3/20 0.54
CYP1A2 P05177 3/20 0.54
CYP2C9 P11712 2/20 0.54
CYP2C19 P33261 2/20 0.54
POLB P06746 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
THRB P10828 1/20 0.54
FGFR1 P11362 2/20 0.54
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
PTK2B Q14289 1/20 0.50
PPP1CA P62136 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4017733 0.85 HTT (0.60) HTTMAPTKMT2ANPSR1CYP1A2
SCHEMBL2531256 0.78 HTT (0.78) HTTMAPTKMT2ANPSR1CYP1A2
SCHEMBL6281045 0.77 HTT (0.66) HTTMAPTKMT2ANPSR1CYP1A2
SCHEMBL900306 0.76 HTT (0.75) CYP17A1HTTMAPTKMT2ANPSR1
SCHEMBL30402227 0.76 HTT (0.88) HTTMAPTKMT2ANPSR1POLB
SCHEMBL3419279 0.76 HTT (0.88) HTTMAPTKMT2ANPSR1POLB
Hydrochloric Acid SCHEMBL7975855 0.75 HTT (0.72) CYP17A1HTTMAPTKMT2ANPSR1
SCHEMBL10053918 0.75 HTT (0.72) HTTFGFR1SMN1; SMN2
SCHEMBL18731746 0.75 HTT (0.79) HTTMAPTKMT2ANPSR1CYP1A2
SCHEMBL900209 0.75 CYP17A1 (0.87) CYP17A1CYP1A2FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621913-A1 SUBSTITUTED BENZIMIDAZOLE AND IMIDAZOPYRIDINE COMPOUNDS USEFUL AS CYP17 MODULATORS Bristol-Myers Squibb Company (US) 2013-08-07 EP claimed
WO-2012044537-A1 SUBSTITUTED BENZIMIDAZOLE AND IMIDAZOPYRIDINE COMPOUNDS USEFUL AS CYP17 MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-04-05 WO claimed